Abstract
1 The speed of onset of the pharmacodynamic activity of intravenous propranolol, practolol, oxprenolol and metoprolol was determined, using attenuation of isoprenaline-induced tachycardia as the end-point, in 16 patients with clinically coronary heart disease. 2 Antagonism was evident within 15 s of injection into the central circulation of all four drugs. The time to maximum attenuation of isoprenaline tachycardia was significantly more rapid with propranolol and oxprenolol than with practolol and metoprolol.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alderman E. L., Coltart D. J., Wettach G. E., Harrison D. C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974 Nov;81(5):625–627. doi: 10.7326/0003-4819-81-5-625. [DOI] [PubMed] [Google Scholar]
- Combs D. T., Martin C. M. Evaluation of isoproterenol as a method of stress testing. Am Heart J. 1974 Jun;87(6):711–715. doi: 10.1016/0002-8703(74)90415-3. [DOI] [PubMed] [Google Scholar]
- Daoud F. S., Surawicz B., Gettes L. S. Effect of isoproterenol on the abnormal T wave. Am J Cardiol. 1972 Dec;30(8):810–819. doi: 10.1016/0002-9149(72)90004-5. [DOI] [PubMed] [Google Scholar]
- Davidson R. G. Detection of carriers of inherited disorders. Birth Defects Orig Artic Ser. 1976;12(6):189–195. [PubMed] [Google Scholar]
- Diaz R. G., Somberg J. C., Freeman E., Levitt B. Withdrawal of propranolol and myocardial infarction. Lancet. 1973 May 12;1(7811):1068–1068. doi: 10.1016/s0140-6736(73)90707-1. [DOI] [PubMed] [Google Scholar]
- McDevitt D. G., Shand D. G. Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther. 1975 Dec;18(6):708–713. doi: 10.1002/cpt1975186708. [DOI] [PubMed] [Google Scholar]
- Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
- Norris R. M., Clarke E. D., Sammel N. L., Smith W. M., Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978 Oct 28;2(8096):907–909. doi: 10.1016/s0140-6736(78)91628-8. [DOI] [PubMed] [Google Scholar]
- Shiroff R. A., Mathis J., Zelis R., Schneck D. W., Babb J. D., Leaman D. M., Hayes A. H., Jr Propranolol rebound--a retrospective study. Am J Cardiol. 1978 Apr;41(4):778–780. doi: 10.1016/0002-9149(78)90831-7. [DOI] [PubMed] [Google Scholar]
- Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs. 1974;7(6):426–461. doi: 10.2165/00003495-197407060-00004. [DOI] [PubMed] [Google Scholar]
- Thadani U., Davidson C., Singleton W., Taylor S. H. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 5;300(14):750–755. doi: 10.1056/NEJM197904053001402. [DOI] [PubMed] [Google Scholar]
- Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wexler H., Kuaity J., Simonson E. Electrocardiographic effects of isoprenaline in normal subjects and patients with coronary atherosclerosis. Br Heart J. 1971 Sep;33(5):759–764. doi: 10.1136/hrt.33.5.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yusuf S., Ramsdale D., Peto R., Furse L., Bennett D., Bray C., Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet. 1980 Aug 9;2(8189):273–276. doi: 10.1016/s0140-6736(80)90231-7. [DOI] [PubMed] [Google Scholar]